Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2025-01-28

Clinical Trial Update: UCSF BP Activate Letter Study [NA]

View source ↗

Summary

The UCSF BP Activate Letter Study has completed. It concerns hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, San Francisco | Conditions: Hypertension | NA | Status: COMPLETED